Hong Zhang

Radiation Oncology
1000 South Ave
Rochester, NY 14620

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

A Phase 1/2 study of ontorpacept (TTI-621) in combination with doxorubicin in patients with unresectable or metastatic high-grade leiomyosarcoma.

A Phase 1/2 study of ontorpacept (TTI-621) in combination with doxorubicin in patients with unresectable or metastatic high-grade leiomyosarcoma.

Journal: British journal of cancer
Published: January 14, 2026
Showing 1-1 of 1

Last Updated: 09/26/2026